European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 19, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 15:15

Human medicines European public assessment report (EPAR): Ravicti, glycerol phenylbutyrate, Date of authorisation: 26/11/2015, Revision: 19, Status: Authorised

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 15:00

Human medicines European public assessment report (EPAR): Enzalutamide Viatris, enzalutamide, Date of authorisation: 22/08/2024, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 14:52

Human medicines European public assessment report (EPAR): Adynovi, rurioctocog alfa pegol, Date of authorisation: 08/01/2018, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 14:45

Human medicines European public assessment report (EPAR): Icandra (previously Vildagliptin / metformin hydrochloride Novartis), vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 29, Status: Authorised

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 14:35

Human medicines European public assessment report (EPAR): Zomarist, vildagliptin,metformin, Date of authorisation: 30/11/2008, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR): Voraxaze, glucarpidase, Date of authorisation: 11/01/2022, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 5 December 2025 - 14:15

Human medicines European public assessment report (EPAR): Voraxaze, glucarpidase, Date of authorisation: 11/01/2022, Revision: 2, Status: Authorised

15th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2025, 09:00 (CET) to 11 December 2025, 10:00 (CET)

Submitted by Anonymous (not verified) on 5 December 2025 - 14:15

15th Industry Standing Group (ISG) meeting, Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 December 2025, 09:00 (CET) to 11 December 2025, 10:00 (CET)

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More
randomness